VCU Massey Cancer Center becomes first in Virginia to offer FDA-approved CAR T-cell therapy скачать в хорошем качестве

VCU Massey Cancer Center becomes first in Virginia to offer FDA-approved CAR T-cell therapy

VCU Massey Cancer Center is now an official treatment center for Yescarta™ by Kite Pharma for adult patients with recurrent or refractory B-cell lymphoma, making it the first in Virginia to offer an FDA-approved CAR T-cell therapy. Several patients have already undergone consultation for treatment, and Massey will soon be offering another FDA-approved CAR T-cell therapy, KYMRIAH™ by Novartis, for children and young adults with recurrent or refractory B-cell acute lymphoblastic leukemia. Website: http://www.masseycit.org Facebook:   / vcumasseycancercenter   Twitter:   / vcumassey   VCU Massey Cancer Center is one of only 68 National Cancer Institute-designated institutions in the country that leads and shapes America's cancer research efforts. Working with all kinds of cancers, Massey conducts basic, translational and clinical cancer research, provides state-of-the-art treatments and clinical trials, and promotes cancer prevention and education. Since 1974, Massey has served as an internationally recognized center of excellence. It offers the most cancer clinical trials in Virginia and serves patients at 10 locations. Its 1,000-plus researchers, clinicians and staff members are dedicated to improving the quality of human life by developing and delivering effective means to prevent, control and ultimately cure cancer. Visit Massey online at www.massey.vcu.edu or call 877-4-MASSEY for more information.